Reviva Pharmaceuticals Holdings, Inc. Warrant

Reviva Pharmaceuticals Holdings, Inc. Warrant is a financial instrument providing investors with the option to purchase common shares of Reviva Pharmaceuticals Holdings, Inc., a pharmaceutical company focused on developing therapies for central nervous system (CNS) and metabolic disorders. The warrant allows investors to buy shares at a predetermined price before an expiration date, offering a potential gateway to invest in the company's future prospects. These warrants are often used by investors seeking leverage, as they require a smaller initial investment compared to directly purchasing stock. Reviva Pharmaceuticals is involved in crucial research and development within the biotechnology sector, emphasizing the treatment of conditions such as schizophrenia, bipolar disorder, and depression. Warrants like these play a significant role in the capital markets by providing companies with a mechanism to incentivize investors and potentially secure future equity funding. They also allow investors to align their investment strategies with the company’s growth trajectory, particularly in the evolving landscape of drug development and therapeutic innovations.